MN

Michel Nussenzweig

TU The Rockefeller University: 30 patents #5 of 698Top 1%
Caltech: 22 patents #61 of 4,321Top 2%
📍 New York, NY: #446 of 20,192 inventorsTop 3%
🗺 New York: #3,998 of 115,490 inventorsTop 4%
Overall (All Time): #121,054 of 4,157,543Top 3%
30
Patents All Time

Issued Patents All Time

Showing 1–25 of 30 patents

Patent #TitleCo-InventorsDate
12428472 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Johannes Scheid, Pamela J. Bjorkman, Ron Diskin 2025-09-30
12338277 Broadly neutralizing antibodies that target HIV ENV V3 N-glycans Hugo Mouquet, Pamela J. Bjorkman, Louise Scharf 2025-06-24
12239698 HIV vaccine immunogens Pamela J. Bjorkman, Amelia Escolano, Harry Gristick 2025-03-04
12234278 Combination of broadly neutralizing HIV antibodies and viral inducers Ariel Halper-Stromberg, Ching-Lan Lu 2025-02-25
12173052 HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants Ron Diskin, Anthony West, Pamela J. Bjorkman 2024-12-24
12071470 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Johannes Scheid, Pamela J. Bjorkman, Ron Diskin 2024-08-27
12060411 Neutralizing anti-SARS-CoV-2 antibodies Zijun Wang 2024-08-13
12054538 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 Ron Diskin, Pamela J. Bjorkman, Johannes Scheid 2024-08-06
11919945 Neutralizing anti-SARS-CoV-2 antibodies 2024-03-05
11897940 Broadly neutralizing anti-HIV-1 antibodies and methods of use thereof Natalia T. Freund, Pamela J. Bjorkman, Louise Scharf 2024-02-13
11649276 Broadly-neutralizing anti-HIV antibodies Hugo Mouquet, Pamela J. Bjorkman, Louise Scharf 2023-05-16
11634477 Neutralizing anti-SARS-CoV-2 antibodies and methods of use thereof Davide F. Robbiani 2023-04-25
11634478 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Johannes Scheid, Pamela J. Bjorkman, Ron Diskin 2023-04-25
11472868 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 Ron Diskin, Pamela J. Bjorkman, Johannes Scheid 2022-10-18
11370830 Neutralizing antibodies that bind to the zika virus domain III envelope region Davide F. Robbiani 2022-06-28
11325966 Broadly neutralizing anti-HIV-1 antibodies and methods of use thereof Natalia T. Freund, Pamela J. Bjorkman, Louise Scharf 2022-05-10
11155605 Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunits Pamela J. Bjorkman, Louise Scharf, Johannes Scheid 2021-10-26
11149081 HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants Ron Diskin, Anthony West, Pamela J. Bjorkman 2021-10-19
11142564 Broadly-neutralizing anti-HIV antibodies Hugo Mouquet, Pamela J. Bjorkman, Louise Scharf 2021-10-12
10889633 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Johannes Scheid, Pamela J. Bjorkman, Ron Diskin 2021-01-12
10676521 Combination of broadly neutralizing HIV antibodies and viral inducers Ariel Halper-Stromberg, Ching-Lan Lu 2020-06-09
10590187 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120 Ron Diskin, Pamela J. Bjorkman, Johannes Scheid 2020-03-17
10421803 Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits Pamela J. Bjorkman, Louise Scharf, Johannes Scheid 2019-09-24
10392433 Broadly neutralizing antibody directed against HIV-1 GP140 Hugo Mouquet, Pamela J. Bjorkman, Louise Scharf 2019-08-27
10047146 Broadly-neutralizing anti-HIV antibodies Hugo Mouquet, Pamela J. Bjorkman, Louise Scharf 2018-08-14